Clinical Trial Update: The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma [Phase 3]

View source ↗

Summary

Phase 3 trial investigating preemptive gabapentin for chronic neuropathic pain after spinal cord trauma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Due to Trauma
• Spinal Cord Injuries

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Masaryk University | Conditions: Chronic Pain Due to Trauma, Spinal Cord Injuries | Phase 3 | Status: WITHDRAWN